Portal de Periódicos da CAPES

Pulmonary hypertension does not affect the autonomic nervous system dysfunction of sickle cell disease

2009; Wiley; Volume: 84; Issue: 5 Linguagem: Inglês

10.1002/ajh.21377

1096-8652

Jocelyn Inamo, Philippe Connes, Jean Barthélemy, Viorel Dan, Thomas D. Coates, Gylna Loko,

Infectious Encephalopathies and Encephalitis

American Journal of HematologyVolume 84, Issue 5 p. 311-312 CorrespondenceFree Access Pulmonary hypertension does not affect the autonomic nervous system dysfunction of sickle cell disease Jocelyn Inamo, Jocelyn Inamo Département de Cardiologie, CHU de Fort de France, MartiniqueSearch for more papers by this authorPhilippe Connes, Philippe Connes Laboratoire ACTES (EA 3596), Département de Physiologie, Université des Antilles et de la Guyane, Guadeloupe UMR S 763 Inserm/Université des Antilles et de la Guyane, CHU Pointe-à-Pitre, GuadeloupeSearch for more papers by this authorJean-Claude Barthélémy, Jean-Claude Barthélémy Laboratoire de Physiologie Clinique et de l'Exercice, CHU de Saint-Etienne, Saint-Etienne, PRES Lyon 42023, FranceSearch for more papers by this authorViorel Dan, Viorel Dan Département de Cardiologie, CHU de Fort de France, MartiniqueSearch for more papers by this authorThomas Coates, Thomas Coates Department of Pediatrics, Children's Hospital Los Angeles, Los AngelesSearch for more papers by this authorGylna Loko, Gylna Loko Laboratoire ACTES (EA 3596), Département de Physiologie, Université des Antilles et de la Guyane, Guadeloupe Centre Intégré de la Drépanocytose, CH du Lamentin, MartiniqueSearch for more papers by this author Jocelyn Inamo, Jocelyn Inamo Département de Cardiologie, CHU de Fort de France, MartiniqueSearch for more papers by this authorPhilippe Connes, Philippe Connes Laboratoire ACTES (EA 3596), Département de Physiologie, Université des Antilles et de la Guyane, Guadeloupe UMR S 763 Inserm/Université des Antilles et de la Guyane, CHU Pointe-à-Pitre, GuadeloupeSearch for more papers by this authorJean-Claude Barthélémy, Jean-Claude Barthélémy Laboratoire de Physiologie Clinique et de l'Exercice, CHU de Saint-Etienne, Saint-Etienne, PRES Lyon 42023, FranceSearch for more papers by this authorViorel Dan, Viorel Dan Département de Cardiologie, CHU de Fort de France, MartiniqueSearch for more papers by this authorThomas Coates, Thomas Coates Department of Pediatrics, Children's Hospital Los Angeles, Los AngelesSearch for more papers by this authorGylna Loko, Gylna Loko Laboratoire ACTES (EA 3596), Département de Physiologie, Université des Antilles et de la Guyane, Guadeloupe Centre Intégré de la Drépanocytose, CH du Lamentin, MartiniqueSearch for more papers by this author First published: 11 February 2009 https://doi.org/10.1002/ajh.21377Citations: 8AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References 1 Gladwin MT,Sachdev V,Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004; 350: 886– 895. 2 De Castro LM,Jonassaint JC,Graham FL, et al. Pulmonary hypertension associated with sickle cell disease: Clinical and laboratory endpoints and disease outcomes. Am J Hematol 2008; 83: 19– 25. 3 Anthi A,Machado RF,Jison ML, et al. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med 2007; 175: 1272– 1279. 4 Ataga KI,Moore CG,Hillery CA, et al. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension. Haematologica 2008; 93: 20– 26. 5 Gordeuk VR,Sachdev V,Taylor JG, et al. Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiency. Am J Hematol 2008; 83: 15– 18. 6 Machado RF,Mack AK,Martyr S, et al. Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease. Br J Haematol 2007; 136: 319– 325. 7 Folino AF,Bobbo F,Schiraldi C, et al. Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension. Lung 2003; 181: 321– 328. 8 Sangkatumvong S,Coates TD,Khoo MC. Abnormal autonomic cardiac response to transient hypoxia in sickle cell anemia. Physiol Meas 2008; 29: 655– 668. 9 Pearson SR,Alkon A,Treadwell M, et al. Autonomic reactivity and clinical severity in children with sickle cell disease. Clin Auton Res 2005; 15: 400– 407. 10 Romero Mestre JC,Hernandez A,Agramonte O, et al. Cardiovascular autonomic dysfunction in sickle cell anemia: A possible risk factor for sudden death? Clin Auton Res 1997; 7: 121– 125. 11 Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043– 1065. 12 Connes P,Hue O,Hardy-Dessources MD, et al. Hemorheology and heart rate variability: Is there a relationship? Clin Hemorheol Microcirc 2008; 38: 257– 265. 13 Kato GJ,McGowan V,Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006; 107: 2279– 2285. Citing Literature Volume84, Issue5May 2009Pages 311-312 ReferencesRelatedInformation